AU Patent

AU2012295802B2 — Tricyclic heterocyclic compounds and JAK inhibitors

Assigned to Nissan Chemical Corp · Expires 2017-03-30 · 9y expired

What this patent protects

Novel tricyclic pyrimidine compounds and tricyclic pyridine compounds having JAK inhibitory activities are provided. A tricyclic heterocyclic compound represented by the formula (I

USPTO Abstract

Novel tricyclic pyrimidine compounds and tricyclic pyridine compounds having JAK inhibitory activities are provided. A tricyclic heterocyclic compound represented by the formula (I

Drugs covered by this patent

Patent Metadata

Patent number
AU2012295802B2
Jurisdiction
AU
Classification
—
Expires
2017-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Nissan Chemical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.